Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Lamar Advertising Co
LAMR
$15.9B
| $6.49M | 0.01% |
53,312
+38,912
| +270% | +$5.09M |
|
1277
SPDR Gold MiniShares Trust
GLDM
$30B
| $6.48M | 0.01% |
124,700
+74,500
| +148% | +$3.93M |
|
1278
N-able
NABL
$663M
| $6.48M | 0.01% |
693,417
+131,117
| +23% | +$1.47M |
|
1279
JB Hunt Transport Services
JBHT
$26.5B
| $6.48M | 0.01% |
37,944
-45,000
| -54% | -$8.04M |
|
1280
Cheesecake Factory
CAKE
$5.57B
| $6.47M | 0.01% |
136,445
+126,200
| +1,232% | +$5.81M |
|
1281
Kewaunee Scientific
KEQU
$105M
| $6.47M | 0.01% |
104,566
-12,545
| -11% | -$511K |
|
1282
PROG Holdings
PRG
$1.71B
| $6.43M | 0.01% |
152,184
-83,500
| -35% | -$3.86M |
|
|
ITOS
1283
DELISTED
iTeos Therapeutics
ITOS
| $6.43M | 0.01% |
837,200
+300,800
| +56% | +$2.58M |
|
1284
Houlihan Lokey
HLI
$9.04B
| $6.43M | 0.01% |
37,000
-19,900
| -35% | -$3.5M |
|
1285
HEICO Corp
HEI
$52B
| $6.41M | 0.01% |
26,964
-23,436
| -47% | -$6.07M |
|
1286
Sphere Entertainment
SPHR
$6.19B
| $6.38M | 0.01% |
158,314
-186,021
| -54% | -$7.78M |
|
1287
Relay Therapeutics
RLAY
$4.34B
| $6.38M | 0.01% |
1,549,190
+878,095
| +131% | +$4.78M |
|
1288
Shore Bancshares
SHBI
$802M
| $6.38M | 0.01% |
402,615
-14,600
| -3% | -$226K |
|
1289
Lam Research
LRCX
$412B
| $6.38M | 0.01% |
88,260
-207,310
| -70% | -$15.7M |
|
|
ONL
1290
Orion Office REIT
ONL
$164M
| $6.37M | 0.01% |
1,718,300
-133,354
| -7% | -$525K |
|
1291
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $6.37M | 0.01% |
+240,800
| New | +$6.72M |
|
1292
Emergent Biosolutions
EBS
$238M
| $6.37M | 0.01% |
665,847
+140,900
| +27% | +$1.29M |
|
1293
First Hawaiian
FHB
$3.38B
| $6.33M | 0.01% |
243,900
-179,600
| -42% | -$4.62M |
|
1294
OppFi
OPFI
$613M
| $6.33M | 0.01% |
826,115
+284,900
| +53% | +$1.8M |
|
1295
STAG Industrial
STAG
$7.13B
| $6.33M | 0.01% |
187,100
+25,900
| +16% | +$948K |
|
1296
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.66B
| $6.33M | 0.01% |
243,880
+34,680
| +17% | +$913K |
|
|
MFA
1297
MFA Financial
MFA
$931M
| $6.32M | 0.01% |
620,525
-224,825
| -27% | -$2.58M |
|
1298
MannKind Corp
MNKD
$1.23B
| $6.31M | 0.01% |
981,645
+330,100
| +51% | +$2.21M |
|
1299
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $6.3M | 0.01% |
+164,100
| New | +$6.6M |
|
1300
Aurinia Pharmaceuticals
AUPH
$2.04B
| $6.29M | 0.01% |
700,900
+214,200
| +44% | +$1.75M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.